Avivo Biomedical Inc.: federal grants and contributions: 6 agreements; $23.1M value; 3 departments; 3 programs.
Assay record ASY-CA-0FRDANX1BT · Cite as: Assay Systems, “Avivo Biomedical Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/avivo-biomedical-inc/
A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for a world-first, dual-use universal blood and organ platform.
A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for a world-first, dual-use universal blood and organ platform.
This project aims to further improve the A enzyme production platform for a final product for use all preclinical and subsequent clinical studies, as well as the integration of a new EnzBO1, a B antigen cleaving enzyme, into the enzyme production platform.
This project focuses on further characterizing EnzBO2 by establishing an in-house enzyme kinetic characterization platform, scaling up regulatory quality production of A and B enzymes, and developing a reliable freeze-drying method for preservation and transport.
This project will involve the development of assay systems to test for and assess enzyme quality, purity and stability, as well as support for the development of monoclonal antibodies (for detection of both enzymes, EnzAO1 and EnzAO2) and preparation of technology transfer datasheets.
Funding under the Innovator Stream will support continued research and development of solutions under National Defence’s Funding for Canadian Innovators and Accelerators of DIANA (FCIA-DIANA) program.
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.